 | • レポートコード：MRC2102QY12444 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のリバーロキサバン市場について種類別（2.5 mg、10 mg、15 mg、20 mg）、用途別（急性冠症候群（ACS）、静脈血栓塞栓症（VTE））、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・リバーロキサバン市場の概要 ・世界の主要地域別リバーロキサバン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のリバーロキサバン市場規模2015-2026：種類別（2.5 mg、10 mg、15 mg、20 mg） ・世界のリバーロキサバン市場規模2015-2026：用途別（急性冠症候群（ACS）、静脈血栓塞栓症（VTE）） ・リバーロキサバンの米国市場規模2015-2020 ・リバーロキサバンのヨーロッパ市場規模2015-2020 ・リバーロキサバンの中国市場規模2015-2020 ・リバーロキサバンの日本市場規模2015-2020 ・リバーロキサバンの東南アジア市場規模2015-2020 ・リバーロキサバンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・リバーロキサバンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リバーロキサバンの市場動向・機会・課題 ・調査の結論 |
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.
Market Analysis and Insights: Global Rivaroxaban Market
The global Rivaroxaban market size is projected to reach US$ 12070 million by 2026, from US$ 7520.5 million in 2020, at a CAGR of 8.2% during 2021-2026.
Global Rivaroxaban Scope and Market Size
The global Rivaroxaban market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rivaroxaban market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Rivaroxaban market is segmented into
2.5 mg
10 mg
15 mg
20 mg
Segment by Application, the Rivaroxaban market is segmented into
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
The Rivaroxaban market is analysed and market size information is provided by regions (countries). Segment by Application, the Rivaroxaban market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rivaroxaban Market Share Analysis
Rivaroxaban market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rivaroxaban business, the date to enter into the Rivaroxaban market, Rivaroxaban product introduction, recent developments, etc.
The major vendors covered:
Bayer
J&J
1 Rivaroxaban Market Overview
1.1 Rivaroxaban Product Scope
1.2 Rivaroxaban Segment by Type
1.2.1 Global Rivaroxaban Sales by Type (2020-2026)
1.2.2 2.5 mg
1.2.3 10 mg
1.2.4 15 mg
1.2.5 20 mg
1.3 Rivaroxaban Segment by Application
1.3.1 Global Rivaroxaban Sales Comparison by Application (2020-2026)
1.3.2 Acute Coronary Syndrome (ACS)
1.3.3 Venous Thromboembolism (VTE)
1.4 Rivaroxaban Market Estimates and Forecasts (2015-2026)
1.4.1 Global Rivaroxaban Sales Growth Rate (2015-2026)
1.4.2 Global Rivaroxaban Revenue and Growth Rate (2015-2026)
1.4.3 Global Rivaroxaban Price Trends (2015-2026)
2 Rivaroxaban Estimate and Forecast by Region
2.1 Global Rivaroxaban Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Rivaroxaban Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Rivaroxaban Sales Market Share by Region (2015-2020)
2.2.2 Global Rivaroxaban Revenue Market Share by Region (2015-2020)
2.3 Global Rivaroxaban Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Rivaroxaban Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Rivaroxaban Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Rivaroxaban Estimates and Projections (2015-2026)
2.4.2 Europe Rivaroxaban Estimates and Projections (2015-2026)
2.4.3 China Rivaroxaban Estimates and Projections (2015-2026)
2.4.4 Japan Rivaroxaban Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Rivaroxaban Estimates and Projections (2015-2026)
2.4.6 India Rivaroxaban Estimates and Projections (2015-2026)
3 Global Rivaroxaban Competition Landscape by Players
3.1 Global Top Rivaroxaban Players by Sales (2015-2020)
3.2 Global Top Rivaroxaban Players by Revenue (2015-2020)
3.3 Global Rivaroxaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rivaroxaban as of 2019)
3.4 Global Rivaroxaban Average Price by Company (2015-2020)
3.5 Manufacturers Rivaroxaban Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Rivaroxaban Players (Opinion Leaders)
4 Global Rivaroxaban Market Size by Type
4.1 Global Rivaroxaban Historic Market Review by Type (2015-2020)
4.1.1 Global Rivaroxaban Sales Market Share by Type (2015-2020)
4.1.2 Global Rivaroxaban Revenue Market Share by Type (2015-2020)
4.1.3 Global Rivaroxaban Price by Type (2015-2020)
4.2 Global Rivaroxaban Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Rivaroxaban Sales Forecast by Type (2021-2026)
4.2.2 Global Rivaroxaban Revenue Forecast by Type (2021-2026)
4.2.3 Global Rivaroxaban Price Forecast by Type (2021-2026)
5 Global Rivaroxaban Market Size by Application
5.1 Global Rivaroxaban Historic Market Review by Application (2015-2020)
5.1.1 Global Rivaroxaban Sales Market Share by Application (2015-2020)
5.1.2 Global Rivaroxaban Revenue Market Share by Application (2015-2020)
5.1.3 Global Rivaroxaban Price by Application (2015-2020)
5.2 Global Rivaroxaban Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Rivaroxaban Sales Forecast by Application (2021-2026)
5.2.2 Global Rivaroxaban Revenue Forecast by Application (2021-2026)
5.2.3 Global Rivaroxaban Price Forecast by Application (2021-2026)
6 United States Rivaroxaban Market Facts & Figures
6.1 United States Rivaroxaban Sales Market Share by Company (2015-2020)
6.2 United States Rivaroxaban Sales Market Share by Type (2015-2020)
6.3 United States Rivaroxaban Sales Market Share by Application (2015-2020)
7 Europe Rivaroxaban Market Facts & Figures
7.1 Europe Rivaroxaban Sales Market Share by Company (2015-2020)
7.2 Europe Rivaroxaban Sales Market Share by Type (2015-2020)
7.3 Europe Rivaroxaban Sales Market Share by Application (2015-2020)
8 China Rivaroxaban Market Facts & Figures
8.1 China Rivaroxaban Sales Market Share by Company (2015-2020)
8.2 China Rivaroxaban Sales Market Share by Type (2015-2020)
8.3 China Rivaroxaban Sales Market Share by Application (2015-2020)
9 Japan Rivaroxaban Market Facts & Figures
9.1 Japan Rivaroxaban Sales Market Share by Company (3015-3030)
9.2 Japan Rivaroxaban Sales Market Share by Type (2015-2020)
9.3 Japan Rivaroxaban Sales Market Share by Application (2015-2020)
10 Southeast Asia Rivaroxaban Market Facts & Figures
10.1 Southeast Asia Rivaroxaban Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Rivaroxaban Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Rivaroxaban Sales Market Share by Application (2015-2020)
11 India Rivaroxaban Market Facts & Figures
11.1 India Rivaroxaban Sales Market Share by Company (2015-2020)
11.2 India Rivaroxaban Sales Market Share by Type (2015-2020)
11.3 India Rivaroxaban Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Rivaroxaban Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer Rivaroxaban Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Rivaroxaban Products Offered
12.1.5 Bayer Recent Development
12.2 J&J
12.2.1 J&J Corporation Information
12.2.2 J&J Business Overview
12.2.3 J&J Rivaroxaban Sales, Revenue and Gross Margin (2015-2020)
12.2.4 J&J Rivaroxaban Products Offered
12.2.5 J&J Recent Development
…
13 Rivaroxaban Manufacturing Cost Analysis
13.1 Rivaroxaban Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Rivaroxaban
13.4 Rivaroxaban Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Rivaroxaban Distributors List
14.3 Rivaroxaban Customers
15 Market Dynamics
15.1 Rivaroxaban Market Trends
15.2 Rivaroxaban Opportunities and Drivers
15.3 Rivaroxaban Market Challenges
15.4 Rivaroxaban Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Rivaroxaban Sales (M Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Rivaroxaban Sales (M Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Rivaroxaban Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Rivaroxaban Sales (M Units) by Region (2015-2020)
Table 5. Global Rivaroxaban Sales Market Share by Region (2015-2020)
Table 6. Global Rivaroxaban Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Rivaroxaban Revenue Share by Region (2015-2020)
Table 8. Global Rivaroxaban Sales (M Units) Forecast by Region (2021-2026)
Table 9. Global Rivaroxaban Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Rivaroxaban Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Rivaroxaban Revenue Share Forecast by Region (2021-2026)
Table 12. Global Rivaroxaban (M Units) of Key Companies (2015-2020)
Table 13. Global Rivaroxaban Sales Share by Company (2015-2020)
Table 14. Global Rivaroxaban Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Rivaroxaban Revenue Share by Company (2015-2020)
Table 16. Global Rivaroxaban by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rivaroxaban as of 2019)
Table 17. Global Rivaroxaban Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Rivaroxaban Manufacturing Sites and Area Served
Table 19. Manufacturers Rivaroxaban Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Rivaroxaban Players
Table 22. Global Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 23. Global Rivaroxaban Sales Share by Type (2015-2020)
Table 24. Global Rivaroxaban Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Rivaroxaban Price (M Units) by Type (2015-2020)
Table 26. Global Rivaroxaban Sales Share by Type (2021-2026)
Table 27. Global Rivaroxaban Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Rivaroxaban Revenue Share by Type (2021-2026)
Table 29. Global Rivaroxaban Price (M Units) by Type (2021-2026)
Table 30. Global Rivaroxaban Sales (M Units) by Application (2015-2020)
Table 31. Global Rivaroxaban Sales Share by Application (2015-2020)
Table 32. Global Rivaroxaban Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Rivaroxaban Price (M Units) by Application (2015-2020)
Table 34. Global Rivaroxaban Sales (M Units) by Application (2021-2026)
Table 35. Global Rivaroxaban Sales Share by Application (2021-2026)
Table 36. Global Rivaroxaban Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Rivaroxaban Revenue Share by Application (2021-2026)
Table 38. Global Rivaroxaban Price (M Units) by Application (2021-2026)
Table 39. United States Rivaroxaban Sales (M Units) by Company (2015-2020)
Table 40. United States Rivaroxaban Sales Market Share by Company (2015-2020)
Table 41. United States Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 42. United States Rivaroxaban Sales Market Share by Type (2015-2020)
Table 43. United States Rivaroxaban Sales (M Units) by Application (2015-2020)
Table 44. United States Rivaroxaban Sales Market Share by Application (2015-2020)
Table 45. Europe Rivaroxaban Sales (M Units) by Company (2015-2020)
Table 46. Europe Rivaroxaban Sales Market Share by Company (2015-2020)
Table 47. Europe Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 48. Europe Rivaroxaban Sales Market Share by Type (2015-2020)
Table 49. Europe Rivaroxaban Sales (M Units) by Application (2015-2020)
Table 50. Europe Rivaroxaban Sales Market Share by Type (2015-2020)
Table 51. China Rivaroxaban Sales (M Units) by Company (2015-2020)
Table 52. China Rivaroxaban Sales Market Share by Company (2015-2020)
Table 53. China Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 54. China Rivaroxaban Sales Market Share by Type (2015-2020)
Table 55. China Rivaroxaban Sales (M Units) by Application (2015-2020)
Table 56. China Rivaroxaban Sales Market Share by Application (2015-2020)
Table 57. Japan Rivaroxaban Sales (M Units) by Company (2015-2020)
Table 58. Japan Rivaroxaban Sales Market Share by Company (2015-2020)
Table 59. Japan Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 60. Japan Rivaroxaban Sales Market Share by Type (2015-2020)
Table 61. Japan Rivaroxaban Sales (M Units) by Application (2015-2020)
Table 62. Japan Rivaroxaban Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Rivaroxaban Sales (M Units) by Company (2015-2020)
Table 64. Southeast Asia Rivaroxaban Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 66. Southeast Asia Rivaroxaban Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 68. Southeast Asia Rivaroxaban Sales Market Share by Application (2015-2020)
Table 69. India Rivaroxaban Sales (M Units) by Company (2015-2020)
Table 70. India Rivaroxaban Sales Market Share by Company (2015-2020)
Table 71. India Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 72. India Rivaroxaban Sales Market Share by Type (2015-2020)
Table 73. India Rivaroxaban Sales (M Units) by Application (2015-2020)
Table 74. India Rivaroxaban Sales Market Share by Application (2015-2020)
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Rivaroxaban Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Bayer Rivaroxaban Product
Table 79. Bayer Recent Development
Table 80. J&J Corporation Information
Table 81. J&J Description and Business Overview
Table 82. J&J Rivaroxaban Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. J&J Rivaroxaban Product
Table 84. J&J Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Rivaroxaban Distributors List
Table 88. Rivaroxaban Customers List
Table 89. Rivaroxaban Market Key Trends
Table 90. Rivaroxaban Key Opportunities and Drivers
Table 91. Rivaroxaban Market Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Rivaroxaban Product Picture
Figure 2. Global Rivaroxaban Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Rivaroxaban Market Share by Application in 2020 & 2026
Figure 6. Acute Coronary Syndrome (ACS) Examples
Figure 7. Venous Thromboembolism (VTE) Examples
Figure 8. Global Rivaroxaban Sales (M Units) Growth Rate (2015-2026)
Figure 9. Global Rivaroxaban Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Rivaroxaban Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Rivaroxaban Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Rivaroxaban Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Rivaroxaban Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Rivaroxaban Sales (M Units) Growth Rate (2015-2026)
Figure 15. Europe Rivaroxaban Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Rivaroxaban Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Rivaroxaban Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Rivaroxaban Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Rivaroxaban Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Rivaroxaban Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Rivaroxaban Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Rivaroxaban Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Rivaroxaban Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Rivaroxaban Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Rivaroxaban Players Market Share by Revenue in Rivaroxaban 2015 & 2019
Figure 26. Rivaroxaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Rivaroxaban Revenue Share by Type (2015-2020)
Figure 28. Global Rivaroxaban Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Rivaroxaban Revenue Share by Application (2015-2020)
Figure 30. Global Rivaroxaban Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Rivaroxaban Sales Market Share by Type in 2019
Figure 32. United States Rivaroxaban Sales Market Share by Type in 2019
Figure 33. Europe Rivaroxaban Sales Market Share by Company in 2019
Figure 34. Europe Rivaroxaban Sales Market Share by Type in 2019
Figure 35. Europe Rivaroxaban Sales Market Share by Application in 2019
Figure 36. China Rivaroxaban Sales Market Share by Company in 2019
Figure 37. China Rivaroxaban Sales Market Share by Type in 2019
Figure 38. China Rivaroxaban Sales Market Share by Application in 2019
Figure 39. Japan Rivaroxaban Sales Market Share by Company in 2019
Figure 40. Japan Rivaroxaban Sales Market Share by Type in 2019
Figure 41. Japan Rivaroxaban Sales Market Share by Application in 2019
Figure 42. Southeast Asia Rivaroxaban Sales Market Share by Company in 2019
Figure 43. Southeast Asia Rivaroxaban Sales Market Share by Type in 2019
Figure 44. Southeast Asia Rivaroxaban Sales Market Share by Application in 2019
Figure 45. India Rivaroxaban Sales Market Share by Company in 2019
Figure 46. India Rivaroxaban Sales Market Share by Type in 2019
Figure 47. India Rivaroxaban Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Rivaroxaban
Figure 50. Manufacturing Process Analysis of Rivaroxaban
Figure 51. Rivaroxaban Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
経口抗凝固剤の世界市場レポート2020 Oral anticoagulants act on multiple coagulation factors by taking drugs to remove or inhibit certain coagulation factors in the blood and prevent blood coagulation. Market Analysis and Insights: Global Oral Anticoagulant Market The global Oral Anticoagulant market size is projected to reach US$ XX m…- 静脈ステントの世界市場レポート2020 This report studies the Venous Stents market. Venous stents are metal mesh tubes that expand against blocked or narrowed vein walls. They act as a scaffold to keep veins open. In most cases, surgeons place venous stents in larger, central veins, such as those found in the legs, chest and abdomen. Fo…
- 月経前症候群薬の世界市場レポート2020 Market Analysis and Insights: Global Premenstrual Syndrome Medicine Market The global Premenstrual Syndrome Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Premenstrual Syndrome Medicine Scope and Market Size T…
- 冠動脈粥腫切除機器の世界市場レポート2020 Atherectomy is defined as minimally invasive surgery for removal of plaque blockages from coronary. Atherectomy is a minimally invasive endovascular surgery technique for removing atherosclerosis from blood vessels within the body. It is an alternative to angioplasty for the treatment of peripheral …
- 過敏性腸症候群（IBS）の世界市場レポート2020 Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predomin…